PL3544630T3 - Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych - Google Patents

Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych

Info

Publication number
PL3544630T3
PL3544630T3 PL17808402T PL17808402T PL3544630T3 PL 3544630 T3 PL3544630 T3 PL 3544630T3 PL 17808402 T PL17808402 T PL 17808402T PL 17808402 T PL17808402 T PL 17808402T PL 3544630 T3 PL3544630 T3 PL 3544630T3
Authority
PL
Poland
Prior art keywords
treatment
nutritional composition
resistant starch
neoplastic diseases
starch useful
Prior art date
Application number
PL17808402T
Other languages
English (en)
Inventor
Valerio PAZIENZA
Original Assignee
Fondazione Di Religione E Di Culto "Casa Sollievo Della Sofferenza" - Opera Di San Pio Da Pietrelcina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondazione Di Religione E Di Culto "Casa Sollievo Della Sofferenza" - Opera Di San Pio Da Pietrelcina filed Critical Fondazione Di Religione E Di Culto "Casa Sollievo Della Sofferenza" - Opera Di San Pio Da Pietrelcina
Publication of PL3544630T3 publication Critical patent/PL3544630T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A23L29/219Chemically modified starch; Reaction or complexation products of starch with other chemicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17808402T 2016-11-28 2017-11-27 Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych PL3544630T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16200981.5A EP3326650A1 (en) 2016-11-28 2016-11-28 Nutritional composition with resistant starch useful in the treatment of neoplastic diseases
EP17808402.6A EP3544630B1 (en) 2016-11-28 2017-11-27 Nutritional composition with resistant starch useful in the treatment of neoplastic diseases
PCT/EP2017/080468 WO2018096131A1 (en) 2016-11-28 2017-11-27 Nutritional composition with resistant starch useful in the treatment of neoplastic diseases

Publications (1)

Publication Number Publication Date
PL3544630T3 true PL3544630T3 (pl) 2021-10-25

Family

ID=57485305

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17808402T PL3544630T3 (pl) 2016-11-28 2017-11-27 Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych

Country Status (12)

Country Link
US (1) US11382928B2 (pl)
EP (2) EP3326650A1 (pl)
AU (1) AU2017364260A1 (pl)
CA (1) CA3045073C (pl)
DK (1) DK3544630T3 (pl)
ES (1) ES2870917T3 (pl)
HR (1) HRP20210630T1 (pl)
HU (1) HUE054506T2 (pl)
LT (1) LT3544630T (pl)
PL (1) PL3544630T3 (pl)
PT (1) PT3544630T (pl)
WO (1) WO2018096131A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN880996A0 (en) * 1996-03-20 1996-04-18 Arnott's Biscuits Limited Selection and/or enhancement of resident microorganisms in the gastrointestinal tract
US20070269580A1 (en) * 2006-05-19 2007-11-22 Charles Werstak Processes for producing food compositions including legume products and products produced therefrom
WO2012113415A1 (en) * 2011-02-24 2012-08-30 N.V. Nutricia Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients
AU2015319791A1 (en) * 2014-09-19 2017-02-23 Nestec Sa Treatment of cancer with alpha-amylase inhibitor in companion animals

Also Published As

Publication number Publication date
US20190343866A1 (en) 2019-11-14
PT3544630T (pt) 2021-04-26
EP3544630A1 (en) 2019-10-02
EP3326650A1 (en) 2018-05-30
US11382928B2 (en) 2022-07-12
CA3045073A1 (en) 2018-05-31
DK3544630T3 (da) 2021-04-26
EP3544630B1 (en) 2021-03-24
CA3045073C (en) 2024-05-21
WO2018096131A1 (en) 2018-05-31
AU2017364260A1 (en) 2019-06-20
HUE054506T2 (hu) 2021-09-28
HRP20210630T1 (hr) 2021-06-25
ES2870917T3 (es) 2021-10-28
AU2017364260A2 (en) 2019-06-27
LT3544630T (lt) 2021-07-26

Similar Documents

Publication Publication Date Title
GB2560282B (en) Illumination content production and use
HK1256283A1 (zh) 治療癌症有用的二氫咪唑並吡嗪酮衍生物
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
HK1245658A1 (zh) 可用於治療ibd患者的營養組合物
ZA201804950B (en) Indolinones compounds and their use in the treatment of fibrotic diseases
LT3405213T (lt) Bakteriniai šešėliai, skirti panaudoti vėžio gydyme
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
GB201700692D0 (en) Novel compounds and their use in the treatment of schistosomiasis
IL269121A (en) Usl-311 for use in the treatment of cancer
RS65009B1 (sr) Sastav za upotrebu u lečenju crevnih promena
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases
GB201514018D0 (en) Novel tricyclic compounds and their use in the treatment of cancer
IL270788A (en) Sulfonylurea compounds in the treatment of disease associated with uv-induced damage
PL3544630T3 (pl) Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych
HK1209369A1 (en) Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases
SG10201500884WA (en) Manufacture Of Vascular Smooth Muscle Cells And The Use
GB201616087D0 (en) Algae comprising therapeutic and/or nutritional agents
AU2016143V (en) Suncap5 Liriope muscari
GB201511772D0 (en) Improvements in the treatment of ash
PL3161209T3 (pl) Zastosowanie mąki z pszenicy w procesie papierniczym
AU358216S (en) A flexible gemstone setting